Lepu Medical Technology (Beijing). 

¥16.35
0
-¥0.29-1.74% Friday 07:00

統計

當日最高
16.57
當日最低
16.27
52週高點
20.62
52週低點
10.68
成交量
21,186,718
平均成交量
-
市值
30.75B
本益比
25.47
股息殖利率
1.82%
股息
0.3

即將到來

股息

1.82%股息殖利率
Sep 25
¥0.16
Jun 25
¥0.14
Sep 24
¥0.14
Jun 24
¥0.33
Jun 23
¥0.34
10年成長
14.04%
5年成長
5.48%
3年成長
-4.42%
1年成長
不適用

財報

23Apr預期
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
下一步
0.06
0.13
0.2
0.27
預期EPS
0.06764604210784
實際EPS
不適用

財務

4.13%利潤率
有盈利
2019
2020
2021
2022
2023
2024
11.95B營收
493.88M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 300003.SZ 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Lepu Medical Technology (Beijing) Co., Ltd. develops, produces, and sells medical devices and equipment. The company offers cardiovascular interventional products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, tourniquets, inflation devices, and PCI accessories; structural heart diseases products, including occluders, vascular plugs, delivery systems, and mechanical heart valves; cardiac rhythm management products, which include pacemakers, equipment, leads, and electrophysiology; off-pump coronary artery bypass grafting surgical cardiology products; and PTA balloons and guide wires peripheral interventional products. It also provides critical care products, such as vascular access products, needle free connectors, blood samplers, and pressure transducers; floor and suspended type digital subtraction angiography systems; in vitro diagnostic equipment and biomarkers; hemodialysis catheters and hollow fiber dialyzers; and general surgery products, including surgical staplers and endo surgery accessories. In addition, the company offers cardiovascular system drugs, such as antithrombotic, hypolipidemic, antihypertensive, antianginal, and heart failure treatment; ß-lactamase antibiotics and antifungal antimicrobial drugs; central nervous system drugs comprises painkillers and antidepressants; gastric/duodenal ulcer and chronic liver disease treatment drugs; respiratory system drugs; hypoproteinemia drugs; and activating blood circulation drugs. Further, it provides precision medicine, ECG telemonitoring, and cardiovascular disease consulting and management center services; medical S&T incubation and equity investment, and medical financial services; consultation, online pharmacy, and household medical equipment services; smart devices; and specialized hospital services for cardiovascular diseases, as well as involved in the co-construction of Cath lab. The company was founded in 1999 and is headquartered in Beijing, China.
Show more...
執行長
Mr. Zhong Jie Pu
員工
10941
國家
中國
ISIN
CNE100000H44

上市

0 Comments

分享你的想法

FAQ

Lepu Medical Technology (Beijing). 今天的股價是多少?
300003.SZ 目前價格為 ¥16.35 CNY,過去 24 小時下跌了 -1.74%。在圖表上更密切關注 Lepu Medical Technology (Beijing). 股票的表現。
Lepu Medical Technology (Beijing). 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Lepu Medical Technology (Beijing). 的股票以代號 300003.SZ 進行交易。
Lepu Medical Technology (Beijing). 的股價在上漲嗎?
300003.SZ 股票較上週下跌 -0.61%,本月下跌 -5.49%,但在過去一年中,Lepu Medical Technology (Beijing). 上漲了 +50.41%。
Lepu Medical Technology (Beijing). 的市值是多少?
今天 Lepu Medical Technology (Beijing). 的市值為 30.75B
Lepu Medical Technology (Beijing). 下一次財報日期是什麼時候?
Lepu Medical Technology (Beijing). 將於 April 23, 2026 公布下一次財報。
Lepu Medical Technology (Beijing). 上一季度的財報如何?
300003.SZ 上一季度的財報為每股 0.16 CNY,預估為 0.15 CNY,帶來 +3.51% 的驚喜。下一季度的預估財報為每股 不適用 CNY。
Lepu Medical Technology (Beijing). 去年的營收是多少?
Lepu Medical Technology (Beijing). 去年的營收為 11.95BCNY。
Lepu Medical Technology (Beijing). 去年的淨利是多少?
300003.SZ 去年的淨收益為 493.88MCNY。
Lepu Medical Technology (Beijing). 會發放股息嗎?
是的,300003.SZ 的股息每 半年一次 發放一次。每股最新股息為 0.16 CNY。截至今日,股息殖利率(FWD)% 為 1.82%。
Lepu Medical Technology (Beijing). 有多少名員工?
截至 April 19, 2026,公司共有 10,941 名員工。
Lepu Medical Technology (Beijing). 位於哪個產業?
Lepu Medical Technology (Beijing).從事於Health & Wellness產業。
Lepu Medical Technology (Beijing). 何時完成拆股?
Lepu Medical Technology (Beijing). 上次拆股發生於 June 23, 2016,比例為 2:1。
Lepu Medical Technology (Beijing). 的總部在哪裡?
Lepu Medical Technology (Beijing). 的總部位於 中國 的 Beijing。